Spanish biotech SpliceBio has raised $135 million in financing that will help it move a gene-editing therapy for an inherited retinal disease (IRD) through clinical testing. SpliceBio's lead in-house ...
The DBR Splice System uses the D51 DBR Splice Bar combined with the D51A DBR Form Saver to perform in tension and compression in excess of a Type 1 (125% specified yield) splice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results